Showing results (21-30 of 41) with videos related to
Sort By:
Pageof 5
Cell Metabolism|February 19, 2019
Serine Metabolism Supports Macrophage IL-1β ProductionArianne E Rodriguez, Gregory S Ducker, Leah K Billingham, et al.Cancer & Metabolism|August 28, 2025
Hyperlipidemia drives tumor growth in a mouse model of obesity-accelerated breast cancer growthRenan Fl Vieira, Sawyer R Sanchez, Menusha Arumugam, et al.Biorxiv : the Preprint Server for Biology|October 31, 2023
Phospholipid isotope tracing reveals β-catenin-driven suppression of phosphatidylcholine metabolism in hepatocellular carcinomaChad VanSant-Webb, Hayden K Low, Junko Kuramoto, et al.Biorxiv : the Preprint Server for Biology|August 8, 2025
microRNA-21 promotes dysregulated lipid metabolism and hepatocellular carcinomaChad VanSant-Webb, Jessye C Castro, Audrey Y Su, et al.Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|May 25, 2024
Phospholipid isotope tracing suggests β-catenin-driven suppression of phosphatidylcholine metabolism in hepatocellular carcinomaChad VanSant-Webb, Hayden K Low, Junko Kuramoto, et al.Disease Models & Mechanisms|January 26, 2026
microRNA-21 promotes dysregulated lipid metabolism and hepatocellular carcinomaChad VanSant-Webb, Jessye C Castro, Audrey Y Su, et al.Molecular Cancer Research : MCR|January 17, 2020
Metabolic Profiling Reveals a Dependency of Human Metastatic Breast Cancer on Mitochondrial Serine and One-Carbon Unit MetabolismAlbert M Li, Gregory S Ducker, Yang Li, et al.Biorxiv : the Preprint Server for Biology|February 14, 2024
Enhancing mitochondrial pyruvate metabolism ameliorates myocardial ischemic reperfusion injuryJoseph R Visker, Ahmad A Cluntun, Jesse N Velasco-Silva, et al.Elife|August 16, 2020
Mitochondrial pyruvate carrier is required for optimal brown fat thermogenesisVanja Panic, Stephanie Pearson, James Banks, et al.Molecular Cancer Therapeutics|September 27, 2018
A Patient-derived Xenograft Model of Pancreatic Neuroendocrine Tumors Identifies Sapanisertib as a Possible New Treatment for Everolimus-resistant TumorsChester E Chamberlain, Michael S German, Katherine Yang, et al.Pageof 5